Pancreatitis-associated protein as an early marker of asparaginase-associated pancreatitis-Reference-Cited by-同舟云学术

Pancreatitis-associated protein as an early marker of asparaginase-associated pancreatitis

Published:2021-08-09 Issue:14 Volume:62 Page:3506-3510
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lukes Julius¹²^ORCID,Wolthers Benjamin O.³,Altaf Raja Raheel³,Uhrinova Karolina²,Skvarova Kramarzova Karolina¹²,Hermanova Ivana¹²,Simcikova Marketa²,Kicko Peter⁴,Zaliova Marketa¹²⁵^ORCID,Sramkova Lucie¹²⁵,Stary Jan²⁵,Trka Jan¹²⁵,Schmiegelow Kjeld³⁶^ORCID,Starkova Julia¹²⁵^ORCID

Affiliation:

1. CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic

2. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

3. Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark

4. Department of Dermatovenereology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

5. University Hospital Motol, Prague, Czech Republic

6. Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark

Funder

Ministry of Health

University Hospital Motol, Prague, Czech Republic

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1961236

Reference20 articles.

1. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis

2. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol

3. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol

4. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age

5. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study